Newsletter | February 27, 2026

02.27.26 -- Company Turnarounds And AI For Infectious Diseases With Seek Labs' Jared Bauer

FEATURED ARTICLE

Company Turnarounds And AI For Infectious Diseases With Seek Labs' Jared Bauer

On this week's episode of the Business of Biotech, Jared Bauer, Cofounder and CEO at Seek Labs, talks about his adventures in company turnarounds and about setting up Seek Labs to improve patient diagnoses and discover and develop treatments for infectious diseases.

INDUSTRY INSIGHTS

How In‑House Plasmid Production Secures Supply Chains

A CDMO with in-house plasmid manufacturing capabilities can help companies accelerate timelines and ensure material availability, ultimately saving time and money throughout their product life cycle.

Decision-Ready Data Restores Clinical Teams' Confidence

The data underlying strategic decisions made by clinical teams often remain fragmented, backward-looking, or insufficiently validated. These teams need decision-ready data that brings clarity where it matters most.

Make Your Production Sites Adaptable And More Efficient

Pharma faces mounting complexity and tighter margins, demanding agile, future-ready production. Discover how smart manufacturing enables faster adaptation and continuous therapy availability.

Harnessing AI For Pre-Award Landscape Analysis And Site Selection

AI-driven insights transform site selection and feasibility, enabling faster decisions and reducing risk. Predictive modeling and real-time data improve pre-award planning and trial outcomes.

Understanding T3P From Start To Finish

T3P is a versatile reagent for many kinds of functional group transformations. Review its advantages and recommendations for use.

CONTRIBUTE TO LIFE SCIENCE LEADER

Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director.